MMP20: A Potential Drug Target for Neurological Disorders (G9313)

Target Name: MMP20

NCBI ID: G9313

MMP20

MMP20: A Potential Drug Target for Neurological Disorders

MMP20, or meningitum-associated protein 20, is a protein that is expressed in the meninges, the protective membranes that cover the brain and spinal cord. It has been identified as a potential drug target for various neurological disorders, including multiple sclerosis and neurodegenerative diseases.

MMP20 is a transmembrane protein that is expressed in the meninges, which are the protective membranes that cover the brain and spinal cord. These membranes are composed of phospholipid molecules and protein molecules, and they help to maintain the structural integrity of the central nervous system. MMP20 is one of the proteins that is embedded in the meninges and is involved in the regulation of various cellular processes that are critical for the maintenance of the meninges' integrity.

One of the key functions of MMP20 is its role in the regulation of cell-cell adhesion. MMP20 is a member of the integral membrane protein family, which includes other proteins that are involved in the regulation of cell-cell adhesion, such as cadherins and immunoglobulin E (IgE). These proteins help to maintain the integrity of the blood-brain barrier, which is responsible for ensuring that only certain substances are able to enter the brain and cause it to function properly. MMP20 is also involved in the regulation of the tight junction, which is another important mechanism that helps to maintain the integrity of the blood-brain barrier.

MMP20 is also involved in the regulation of the cytoskeleton. It helps to maintain the integrity of the microtubules, which are the protein structures that are inside the cells and help to regulate the movement of the cells. distribution of organelles in the cells, which is important for the proper functioning of the cells and the organization of the central nervous system.

In addition to its role in cell-cell adhesion and cytoskeleton regulation, MMP20 is also involved in the regulation of inflammation. It is a potent regulator of the production of inflammatory cytokines, which are proteins that are involved in the regulation of the immune response. MMP20 helps to prevent the production of these cytokines by inhibiting the activity of several different enzymes, including the nuclear factor kappa B (NF-kappa-B) and the signal transducer and activator of transcription (STAT3).

One of the ways that MMP20 is involved in inflammation is by its role in the regulation of the production of pro-inflammatory cytokines. MMP20 is a potent inhibitor of the production of these cytokines by blocking the activity of the transcription factor nuclear factor kappa B ( NF-kappa-B), which is a key regulator of inflammation. MMP20 has been shown to have anti-inflammatory effects in several different models of neurodegenerative diseases, including multiple sclerosis and neurofibromatosis.

Another potential mechanism by which MMP20 may be involved in the development of neurodegenerative diseases is its role in the regulation of the transport of certain ions and molecules across the blood-brain barrier. The blood-brain barrier is a specialized barrier that helps to prevent certain substances from entering the brain and causing it to function improperly. MMP20 is involved in the regulation of the transport of several different ions and molecules across the blood-brain barrier, including ions such as calcium and magnesium.

MMP20 is also involved in the regulation of the production of other proteins that are involved in the development and progression of neurodegenerative diseases. For example, it has been shown

Protein Name: Matrix Metallopeptidase 20

Functions: Degrades amelogenin, the major protein component of the enamel matrix and two of the macromolecules characterizing the cartilage extracellular matrix: aggrecan and the cartilage oligomeric matrix protein (COMP). May play a central role in tooth enamel formation. Cleaves aggrecan at the '360-Asn-|-Phe-361' site

The "MMP20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets